| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Generation Bio Co. (GBIO) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. GBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 60.0K | - | - | |
| Dir | 30.0K | - | - | |
| Dir | 30.0K | - | - | |
| Dir | 30.0K | - | - | |
| Dir | 30.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 3,000 | $25.03 | $75,087.00 | -0.7% | -7.0% | -70.7% | |
| Jul 8, 2021 | Kerr Douglas66 | Chief Medical Officer | Sale+OE | 3,518 | $25.20 | $88,670.42 | -0.5% | -8.9% | -70.9% | |
| Jun 24, 2021 | Atlas Venture Associates X, L.P.88 | 10% Owner | Sell | 31,008 | $25.85 | $801,618.16 | -85.4% | -1.0% | -73.1% | |
| Jun 24, 2021 | Rhodes Jason P78 | Director | Sell | 31,008 | $25.85 | $801,618.16 | -85.4% | -1.0% | -73.1% | |
| Jun 23, 2021 | Rhodes Jason P78 | Director | Sell | 185,078 | $25.05 | $4,635,967.02 | -23.1% | +1.6% | -72.7% | |
| Jun 23, 2021 | Atlas Venture Associates X, L.P.88 | 10% Owner | Sell | 185,078 | $25.05 | $4,635,967.02 | -23.1% | +1.6% | -72.7% | |
| Jun 15, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 1,500 | $28.08 | $42,120.00 | -0.8% | +1.5% | -78.2% | |
| Jun 10, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 6,000 | $27.23 | $163,380.00 | -2.9% | -7.1% | -79.2% | |
| May 27, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 1,500 | $34.05 | $51,075.00 | -0.8% | -31.7% | -84.4% | |
| May 11, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 9,000 | $30.61 | $275,534.00 | -1.1% | -22.3% | -81.8% |